Shares of Carl Zeiss Meditec AG (ETR:AFX – Get Free Report) rose 2.3% during trading on Friday . The stock traded as high as €47.00 ($48.45) and last traded at €46.56 ($48.00). Approximately 224,325 shares traded hands during trading, an increase of 138% from the average daily volume of 94,405 shares. The stock had previously closed at €45.52 ($46.93).
Carl Zeiss Meditec Stock Performance
The company has a market cap of $4.12 billion, a PE ratio of 20.18, a P/E/G ratio of 2.83 and a beta of 0.98. The stock’s 50 day simple moving average is €54.62 and its two-hundred day simple moving average is €60.46. The company has a quick ratio of 2.47, a current ratio of 3.51 and a debt-to-equity ratio of 6.74.
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Featured Stories
- Five stocks we like better than Carl Zeiss Meditec
- Investing in Commodities: What Are They? How to Invest in Them
- Insiders Are Selling, But These 3 Stocks Are Must-Buys
- What is a Special Dividend?
- Rivian Defies Doubters: Delivery Triumph Fuels Stock Surge
- What is Short Interest? How to Use It
- Hindenburg Short Report Slams Carvana Over Alleged ‘Grift’
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
